BECTON DICKINSON & CO BDX

Latest FY: 2025 Healthcare Medical Instruments & Supplies
Market Price $183.37
Market Cap $50.13B
P/E Ratio 31.51
Quick Peer Compare (Healthcare):
Revenue (FY 2025) ↑8.2% YoY
$21.84B
3-Yr CAGR: 5.0%
Net Income ↓-1.6% YoY
$1.68B
Net Margin: 7.7%
Free Cash Flow ↓-14.4% YoY
$2.67B
FCF Yield: 5.33%
EPS (Diluted) ↓-0.7% YoY
$5.82
Basic: $5.83
Return on Equity Efficiency
6.6%
ROA: 18.1%

📊 Multi-Year Historical Performance & Trends

Financial Performance History Revenue, Net Income & Free Cash Flow
Margins Trend (%) Gross, Operating & Net Margins
Balance Sheet Strength Cash, Debt & Equity
Cash Flow Generation Operating Cash Flow vs CapEx vs FCF

📈 Year-over-Year (YoY) Growth History (BDX)

All monetary values in millions ($M)
Fiscal Year Revenue Revenue YoY Gross Profit Net Income Net Inc YoY Diluted EPS EPS YoY Op. Cash Flow Free Cash Flow FCF YoY
FY 2016 $12,483.0M $5,991.0M $976.0M $4.38 $2,559.0M $1,866.0M
FY 2017 $12,093.0M -3.1% $5,942.0M $1,100.0M +12.7% $4.49 +2.4% $2,550.0M $1,823.0M -2.3%
FY 2018 $15,983.0M +32.2% $7,262.0M $311.0M -71.7% $0.59 -87.0% $2,865.0M $1,970.0M +8.1%
FY 2019 $17,290.0M +8.2% $8,288.0M $1,233.0M +296.5% $3.84 +556.7% $3,330.0M $2,373.0M +20.5%
FY 2020 $17,117.0M -1.0% $7,577.0M $874.0M -29.1% $2.64 -31.2% $3,539.0M $2,729.0M +15.0%
FY 2021 $20,248.0M +18.3% $9,427.0M $2,092.0M +139.4% $6.68 +152.8% $4,647.0M $3,416.0M +25.2%
FY 2022 $18,870.0M -6.8% $8,477.0M $1,779.0M -15.0% $5.88 -12.0% $2,471.0M $1,498.0M -56.1%
FY 2023 $19,372.0M +2.7% $8,170.0M $1,484.0M -16.6% $4.94 -16.0% $2,990.0M $2,116.0M +41.3%
FY 2024 $20,178.0M +4.2% $9,125.0M $1,705.0M +14.9% $5.86 +18.6% $3,844.0M $3,119.0M +47.4%
FY 2025 $21,840.0M +8.2% $9,925.0M $1,678.0M -1.6% $5.82 -0.7% $3,430.0M $2,670.0M -14.4%
$

Valuation

Market Price $183.37
Market Cap $50.13B
Enterprise Value $67.11B
P/E Ratio 31.51
P/B Ratio 1.99
FCF Yield 5.33%
Dividend Yield N/A
Shares Outstanding 275,540,400
%

Profitability & Margins

Gross Margin 45.44%
Operating Margin 11.81%
Net Margin 7.68%
Return on Equity (ROE) 6.61%
Return on Assets (ROA) 18.13%
Asset Turnover 2.36x
Revenue 3-Yr CAGR 4.99%
🛡️

Financial Health & Liquidity

Current Ratio 2.98
Cash Ratio 0.21
Debt / Equity 0.694
Debt / Assets 1.904
Cash & Equivalents $641.00M
Total Debt $17.62B
Book Value / Share $92.15
💧

Cash Flow Efficiency

Operating Cash Flow $3.43B
Capital Expenditures (CapEx) $760.00M
Free Cash Flow $2.67B
OCF / Revenue 15.71%
FCF / Revenue 12.23%
FCF 3-Yr CAGR 21.25%
🏷️

Per Share Metrics

EPS (Diluted) $5.82
EPS (Basic) $5.83
Dividends / Share N/A
Book Value / Share $92.15
EPS YoY Growth -0.68%
🏛️

Balance Sheet (FY 2025)

Total Assets $9.26B
Total Liabilities $3.10B
Stockholders' Equity $25.39B
Current Assets $9.26B
Current Liabilities $3.10B